{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:08Z","timestamp":1792098308163,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11239-017-1480-6","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T18:36:45Z","timestamp":1487011005000},"page":"446-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery"],"prefix":"10.1007","volume":"43","author":[{"given":"Sean","family":"van Diepen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Podgoreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"1480_CR1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","volume":"116","author":"GJ Murphy","year":"2007","unstructured":"Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544\u20132552","journal-title":"Circulation"},{"key":"1480_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/HCO.0b013e328310fc95","volume":"23","author":"BC Reeves","year":"2008","unstructured":"Reeves BC, Murphy GJ (2008) Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Cardiol 23:607\u2013612","journal-title":"Curr Opin Cardiol"},{"key":"1480_CR3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005\u20131032","journal-title":"Drugs"},{"key":"1480_CR4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","volume":"91","author":"VA Ferraris","year":"2011","unstructured":"Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford-Smith M, Waters J, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG (2011) 2011 Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:944\u2013982","journal-title":"Ann Thorac Surg"},{"key":"1480_CR5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5223(95)70118-4","volume":"110","author":"JM Karski","year":"1995","unstructured":"Karski JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P, Glynn MFX (1995) Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid: double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 110:835\u2013842","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1480_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jcan.2001.23284","volume":"15","author":"G Armellin","year":"2001","unstructured":"Armellin G, Casella S, Guzzinati S, Pasini L, Marcassa A, Giron G (2001) Tranexamic acid in aortic valve replacement. J Cardiothorac Vasc Anesth 15:331\u2013335","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1480_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00000542-200101000-00007","volume":"94","author":"V Casati","year":"2001","unstructured":"Casati V, Bellotti F, Gerli C, Franco A, Oppizzi M, Cossolini M, Calori G, Benussi S, Alfieri O, Torri G (2001) Tranexamic acid administration after cardiac surgery. Anesthesiology 94:8\u201314","journal-title":"Anesthesiology"},{"key":"1480_CR8","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1161\/CIRCULATIONAHA.106.671222","volume":"115","author":"JR Brown","year":"2007","unstructured":"Brown JR, Birkmeyer NJO, O\u2019Connor GT (2007) Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115:2801\u20132813","journal-title":"Circulation"},{"key":"1480_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1503\/cmaj.081109","volume":"180","author":"D Henry","year":"2009","unstructured":"Henry D, Carless P, Fergusson D, Laupacis A (2009) The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 180:183\u2013193","journal-title":"CMAJ"},{"key":"1480_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejcts.2008.11.038","volume":"36","author":"AFL Later","year":"2009","unstructured":"Later AFL, Maas JJ, Engbers FHM, Versteegh MIM, Bruggemans EF, Dion RAE, Klautz RJM (2009) Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery. Eur J Cardiothorac Surg 36:322\u2013329","journal-title":"Eur J Cardiothorac Surg"},{"key":"1480_CR11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","volume":"358","author":"DA Fergusson","year":"2008","unstructured":"Fergusson DA, H\u00e9bert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussi\u00e8res JS, C\u00f4t\u00e9 D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319\u20132331","journal-title":"N Engl J Med"},{"key":"1480_CR12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606424","author":"PS Myles","year":"2016","unstructured":"Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussi\u00e8res JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network (2016) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. doi: 10.1056\/NEJMoa1606424","journal-title":"N Engl J Med"},{"key":"1480_CR13","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/hc4701.099789","volume":"104","author":"MA Costa","year":"2001","unstructured":"Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, Roose PCH, van Geldorp TR, Macaya C, Castanon JL, Fernandez-Avil\u00e8z F, Gonz\u00e1les JH, Heyer G, Unger F, Serruys PW (2001) Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS). Circulation 104:2689\u20132693","journal-title":"Circulation"},{"key":"1480_CR14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0735-1097(01)01481-4","volume":"38","author":"K Klatte","year":"2001","unstructured":"Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A (2001) Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol 38:1070\u20131077","journal-title":"J Am Coll Cardiol"},{"key":"1480_CR15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.105.602370","volume":"114","author":"BL Croal","year":"2006","unstructured":"Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH (2006) Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114:1468\u20131475","journal-title":"Circulation"},{"key":"1480_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.2011.99","volume":"305","author":"MJ Domanski","year":"2011","unstructured":"Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME (2011) Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305:585\u2013591","journal-title":"JAMA"},{"key":"1480_CR17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ahj.2008.01.002","volume":"155","author":"RH Mehta","year":"2008","unstructured":"Mehta RH, Alexander JH, Emery R, Ellis SJ, Hasselblad V, Khalil A, Carrier M, Harrington RA, Tardif J-C (2008) A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II\u2014study design and rationale. Am Heart J 155:600\u2013608","journal-title":"Am Heart J"},{"key":"1480_CR18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.299.15.joc80027","volume":"299","author":"JH Alexander","year":"2008","unstructured":"Alexander JH, Emery RW Jr, Carrier M, Ellis SJ, Mehta RH, Hasselblad V, Menasche P, Khalil A, Cote R, Bennett-Guerrero E, Mack MJ, Schuler G, Harrington RA, Tardif J-C (2008) Efficacy and safety of pyridoxal 5\u2032-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA 299:1777\u20131787","journal-title":"JAMA"},{"key":"1480_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.jvca.2010.08.012","volume":"25","author":"MSC","year":"2011","unstructured":"Adler MSC, Brindle W, Burton G, Gallacher S, Hong FC, Manelius I, Smith A, Ho W, Alston RP, Bhattacharya K (2011) Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 25:26\u201335","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1480_CR20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/BF03011964","volume":"44","author":"P Dryden","year":"1997","unstructured":"Dryden P, O\u2019Connor JP, Jamieson WRE, Reid I, Ansley D, Sadeghi H, Burr L, Munro AI, Merrick P (1997) Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth 44:934\u2013941","journal-title":"Can J Anaesth"},{"key":"1480_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jtcvs.2004.11.015","volume":"130","author":"J Karski","year":"2005","unstructured":"Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, Kucharczyk W, Fedorko L, David T, Cheng D (2005) Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. J Thorac Cardiovascular Surg 130:309\u2013314","journal-title":"J Thorac Cardiovascular Surg"},{"key":"1480_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","volume":"354","author":"DT Mangano","year":"2006","unstructured":"Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353\u2013365","journal-title":"N Engl J Med"},{"key":"1480_CR23","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Circulation 126:2020\u20132035","journal-title":"Circulation"},{"issue":"1","key":"1480_CR24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004311-199500000-00009","volume":"33","author":"D Royston","year":"1995","unstructured":"Royston D (1995) Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid. Int Anesthesiol Clin 33(1):155\u2013179","journal-title":"Int Anesthesiol Clin"},{"key":"1480_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ndt\/16.1.189","volume":"16","author":"AR Odaba\u015f","year":"2001","unstructured":"Odaba\u015f AR, \u00c7etinkaya R, Sel\u00e7uk Y, Kaya H, Co\u015fkun \u00dc (2001) Tranexamic-acid-induced acute renal cortical necrosis in a patient with haemophilia A. Nephrol Dial Transplant 16:189\u2013190","journal-title":"Nephrol Dial Transplant"},{"key":"1480_CR26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ndt\/14.3.750","volume":"14","author":"JR Koo","year":"1999","unstructured":"Koo JR, Lee YK, Kim YS, Cho WY, Kim HK, Won NH (1999) Acute renal cortical necrosis caused by an antifibrinolytic drug (tranexamic acid). Nephrol Dial Transplant 14:750\u2013752","journal-title":"Nephrol Dial Transplant"},{"key":"1480_CR27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2007.10.003","volume":"155","author":"PS Myles","year":"2008","unstructured":"Myles PS, Smith J, Knight J, Cooper DJ, Silbert B, McNeil J, Esmore DS, Buxton B, Krum H, Forbes A, Tonkin A (2008) Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial: rationale and design. Am Heart J 155:224\u2013230","journal-title":"Am Heart J"},{"key":"1480_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/bja\/aei044","volume":"94","author":"P Diprose","year":"2005","unstructured":"Diprose P, Herbertson MJ, O\u2019Shaughnessy D, Deakin CD, Gill RS (2005) Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth 94:271\u2013278","journal-title":"Br J Anaesth"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1480-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1480-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1480-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:27:38Z","timestamp":1498372058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1480-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1480-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}